Eesti -
eesti -
Ravimiamet
teotard toimeainet prolongeeritult vabastav kõvakapsel
krka, d.d., novo mesto - teofülliin - toimeainet prolongeeritult vabastav kõvakapsel - 200mg 40tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
koselugo
astrazeneca ab - selumetinib sulfate - neurofibromatosis 1 - antineoplastilised ained - koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (pn) in paediatric patients with neurofibromatosis type 1 (nf1) aged 3 years and above.